Loading…
Held by 1 funds across 1 fund house in our coverage.
Coverage: 23 of India's largest fund houses — growing.
As of the latest monthly AMC disclosures, Lincoln Pharmaceuticals is held by 1 mutual funds and ETFs in our database. The total value of equity held across these schemes is ₹0 Cr. Among all holding funds, the manager with the highest conviction is (Motilal Oswal MF), which allocates a significant 0.04% of its entire portfolio to Lincoln Pharmaceuticals.
In terms of category distribution, Equity (Diversified) funds hold the largest exposure by market value, representing 1 positions. Across different fund houses, Motilal Oswal MF manages the largest aggregate stake, holding a combined value of ₹0 Cr. This distribution indicates whether the stock is favored by active diversified equity managers or is primarily held in sector-specific/thematic portfolios.
| # | MoM | Rank | ||||
|---|---|---|---|---|---|---|
| 1 | Motilal Oswal S&P BSE Healthcare ETFMotilal Oswal MFEquity (Diversified)₹1.60 L | 0.04% | — | ₹1.60 L | 264 | #109 of 125 |
Portfolios as on: Motilal Oswal MF Aug 2026. ISIN-verified equity positions from public AMC disclosures. Not investment advice.
Weight = the position as a % of that fund's portfolio. MoM = change vs the previous month's disclosure. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).